B

BL PharmTech Corp
KOSDAQ:065170

Watchlist Manager
BL PharmTech Corp
KOSDAQ:065170
Watchlist
Price: 512 KRW -5.88% Market Closed
Market Cap: 13.7B KRW

Net Margin
BL PharmTech Corp

-86.3%
Current
-33%
Average
3.3%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-86.3%
=
Net Income
-6B
/
Revenue
7B

Net Margin Across Competitors

No Stocks Found

BL PharmTech Corp
Glance View

Market Cap
13.7B KRW
Industry
Consumer products

BL Pharmtech Corp. engages in health food industry. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2002-11-19. The firm operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.

Intrinsic Value
675.91 KRW
Undervaluation 24%
Intrinsic Value
Price
B
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-86.3%
=
Net Income
-6B
/
Revenue
7B
What is the Net Margin of BL PharmTech Corp?

Based on BL PharmTech Corp's most recent financial statements, the company has Net Margin of -86.3%.

Back to Top